Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare cancer drug coverage

Executive Summary

Oral dosage forms of cancer drugs would be covered by Medicare under legislation (HR 1787/S 821) introduced April 21 by Rep. Levin (D-Mich.) and April 22 by Sen. Rockefeller (D-W.Va.). The bills also would require Medicare to cover off-label cancer indications of FDA- approved drugs, provided the indications are supported in either peer-reviewed medical literature or the medical compendia.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS022504

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel